Nachrichten und Videos - ORTHOFIX MEDICAL INC.

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the fourth quarter and full-year ended December 31, 2024, and provided full-year 2025 financial guidance. Highlights Record fourth quarter 2024 net sales of $215.7 million, an increase of 8% on a reported and constant currency basis compared to fourth quarter 2023 U.S. Spine Fixation 1 net sales growth of 12% compared to fourth quarter 2023, driven by distribution expansion...

Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego. Management is scheduled to present on Monday, March 10, 2025 at 9:00 am PT. Interested parties can access the live and archived webcast of the presentation in the “Events & Presentations” section of the Orthofix investor relations website at ir.orthofix.com . Internet Posting of Information...

Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2024 financial results on Tuesday, February 25, 2025 before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referencing the event passcode...

Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced that Massimo Calafiore, President and Chief Executive Officer, and Julie Andrews, Chief Financial Officer, will participate in the following investor conferences: Stifel 2024 Healthcare Conference in New York, NY, November 18, 2024, fireside chat at 8:35 AM Eastern Time Stifel MedTech Madness 2024 Annual West Coast Bus Tour in Laguna Beach, CA, December 9, 2024, fireside chat at 8:00 AM Pacific...

OFIX INVESTORS: OrthoFix Medical Inc. Stockholders Should Contact Robbins LLP About Joining the Pending OFIX Class Action PR Newswire SAN DIEGO, Nov. 7, 2024 SAN DIEGO , Nov. 7, 2024 /PRNewswire/ -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of former SeaSpine Holdings Corporation shareholders that purchased or otherwise acquired newly issued Orthofix Medical Inc. (NASDAQ: OFIX) stock in exchange for SeaSpine shares pursuant to the January 5, 2023...

OFIX Investors Have Opportunity to Lead Orthofix Medical Inc. Securities Fraud Lawsuit Filed by the Schall Law Firm PR Newswire LOS ANGELES, Oct. 21, 2024 LOS ANGELES , Oct. 21, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ: OFIX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b -5 promulgated...

OFIX Investors Have Opportunity to Lead Orthofix Medical Inc. Securities Fraud Lawsuit PR Newswire LOS ANGELES, Oct. 18, 2024 LOS ANGELES , Oct. 18, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX ). Class Period: October 11, 2022 – September 12, 2023 Lead Plaintiff Deadline: October 21, 2024 If...

OFIX Investors Have Opportunity to Lead Orthofix Medical Inc. Securities Fraud Lawsuit PR Newswire NEW YORK, Oct. 17, 2024 NEW YORK , Oct. 17, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Orthofix Medical Inc. (NASDAQ: OFIX) between October 11, 2022 and September 12, 2023 , both dates inclusive (the "Class Period"), of the important October 21, 2024 lead plaintiff deadline. So what: If you purchased Orthofix common stock...

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Orthofix Medical Inc. - OFIX PR Newswire NEW YORK, Oct. 17, 2024 NEW YORK , Oct. 17, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail...

The Gross Law Firm Notifies Shareholders of Orthofix Medical Inc.(OFIX) of a Class Action Lawsuit and an Upcoming Deadline PR Newswire NEW YORK, Oct. 17, 2024 NEW YORK , Oct. 17, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Orthofix Medical Inc. (NASDAQ: OFIX). Shareholders who purchased shares of OFIX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not...

OFIX Investors Have Opportunity to Lead Orthofix Medical Inc. Securities Fraud Lawsuit Filed by the Schall Law Firm PR Newswire LOS ANGELES, Oct. 16, 2024 LOS ANGELES , Oct. 16, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ: OFIX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b -5 promulgated...

OFIX Investors Have Opportunity to Lead Orthofix Medical Inc. Securities Fraud Lawsuit PR Newswire BENSALEM, Pa., Oct. 15, 2024 BENSALEM, Pa. , Oct. 15, 2024 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX ). Class Period: October 11, 2022 – September 12, 2023 Lead Plaintiff Deadline: October 21, 2024...

OFIX LAWSUIT ALERT: Levi & Korsinsky Notifies Orthofix Medical Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire NEW YORK, Oct. 15, 2024 NEW YORK , Oct. 15, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Orthofix Medical Inc. ("Orthofix " or the "Company") (NASDAQ: OFIX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Orthofix investors who were adversely affected by alleged securities fraud...

Orthofix Medical Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before October 21, 2024 to Discuss Your Rights - OFIX PR Newswire NEW YORK, Oct. 14, 2024 NEW YORK , Oct. 14, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Orthofix Medical Inc. (NASDAQ: OFIX). Shareholders who purchased shares of OFIX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead...

OFIX Investors Have Opportunity to Lead Orthofix Medical Inc. Securities Fraud Lawsuit PR Newswire NEW YORK, Oct. 11, 2024 NEW YORK , Oct. 11, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Orthofix Medical Inc. (NASDAQ: OFIX) between October 11, 2022 and September 12, 2023 , both dates inclusive (the "Class Period"), of the important October 21, 2024 lead plaintiff deadline. So what: If you purchased Orthofix common stock...

ORTHOFIX MEDICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Orthofix Medical, Inc. - OFIX PR Newswire NEW ORLEANS, Oct. 11, 2024 NEW ORLEANS , Oct. 11, 2024 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana , Charles C. Foti, Jr. , remind investors that they have until October 21, 2024 to file lead...

Orthofix Medical Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - OFIX PR Newswire NEW YORK, Oct. 11, 2024 NEW YORK , Oct. 11, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Orthofix Medical Inc. ("Orthofix " or the "Company") (NASDAQ: OFIX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Orthofix investors who were adversely affected by alleged...

OFIX Investors Have Opportunity to Lead Orthofix Medical Inc. Securities Fraud Lawsuit PR Newswire LOS ANGELES, Oct. 10, 2024 LOS ANGELES , Oct. 10, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX ). Class Period: October 11, 2022 – September 12, 2023 Lead Plaintiff Deadline: October 21, 2024 If you...

Class Action Filed Against Orthofix Medical Inc. (OFIX) Seeking Recovery for Investors - Contact The Gross Law Firm PR Newswire NEW YORK, Oct. 10, 2024 NEW YORK , Oct. 10, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Orthofix Medical Inc. (NASDAQ: OFIX). Shareholders who purchased shares of OFIX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to...

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Orthofix Medical Inc. - OFIX PR Newswire NEW YORK, Oct. 9, 2024 NEW YORK , Oct. 9, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are...